3719 Results

People

  1. Hudis
    Hudis
  2. Lee
    Lee
  3. Giralt
    Giralt
  4. Motzer
    Motzer
  5. Barakat
    Barakat
  6. Scher
    Scher
  7. Ladanyi
    Ladanyi
  8. Levine
    Levine
  9. Chi
    Chi
  10. DeMatteo
    DeMatteo

Groups

  1. Department of Medicine (1284)
  2. Surgery (899)
  3. GSK Faculty (811)
  4. Solid Tumor Oncology Division (708)
  5. Survivorship Research (632)
  6. Sloan Kettering Institute Faculty (579)
  7. Center for Hematologic Malignancies (503)
  8. Department of Pathology and Laboratory Medicine (470)
  9. Population Sciences Research Program (431)
  10. Epidemiology and Biostatistics (426)
  1. "2012"
Formats
  1. Journal Article (2365)
  2. Meeting Abstract (1182)
  3. Book Section (137)
  4. Conference Paper (23)
  5. Book Whole (10)
  6. Correspondence (1)
  7. Editorial (1)
Groups
  1. Department of Medicine (1284)
  2. Surgery (899)
  3. GSK Faculty (811)
  4. Solid Tumor Oncology Division (708)
  5. Survivorship Research (632)
  6. Sloan Kettering Institute Faculty (579)

More Groups

People
  1. Clifford Hudis (64)
  2. Nancy Lee (64)
  3. Sergio Giralt (59)
  4. Robert Motzer (57)
  5. Richard Barakat (54)
  6. Howard Scher (53)

More People

Years
  1. 2012 (3719)
Publications
  1. Journal of Clinical Oncology (315)
  2. Blood (152)
  3. International Journal of Radiation Oncology, Biology, Physics (125)
  4. Cancer Research (110)
  5. Modern Pathology (80)
  6. Gynecologic Oncology (76)

More Publications

Publishers
  1. Elsevier Inc. (519)
  2. American Society of Clinical Oncology (337)
  3. Springer (239)
  4. Nature Publishing Group (202)
  5. Wiley Blackwell (193)
  6. American Association for Cancer Research (192)

More Publishers

Results (3719)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Biomarkers of everolimus efficacy in patients with metastatic renal cell carcinoma (mRCC): Analysis of the phase III RECORD-1 trial
    Meeting Abstract

    Oudard, S.; Escudier, B.; Thompson, J.; Grünwald, V.; Conte, P. F.; Bracarda, S.; Panneerselvam, A.; Gogov, S.; Chen, D.; Motzer, R. J.
    Annals of Oncology (2012)

    Fulltext@MSK | Save
  • Gastrointestinal stromal tumors, somatic mutations, and candidate genetic risk factors
    Meeting Abstract

    O'Brien, K. M.; Orlow, I.; Antonescu, C. R.; Ballman, K.; McCall, L.; DeMatteo, R.; Engel, L. S.
    Genetic Epidemiology (2012)

    Fulltext@MSK | Save
  • Tivozanib pharmacokinetic (PK)/pharmacodynamic (PD) analysis of blood pressure (BP) and soluble vascular endothelial growth factor receptor 2 (sVEGFR2) in patients with advanced renal cell carcinoma (RCC)
    Meeting Abstract

    Nosov, D.; Motzer, R. J.; Loewy, J.; Hodge, L.; Esteves, B.; Berkenblit, A.; Yin, W.; Dykstra, K.; Hutson, T. E.; Cotreau, M.
    Annals of Oncology (2012)

    Fulltext@MSK | Save
  • Novel circulating proteins, single nucleotide polymorphisms (SNPs), and molecular tumor markers as potential biomarkers of sunitinib efficacy in treatment-naïve patients (pts) with advanced renal cell carcinoma (RCC)
    Meeting Abstract

    Motzer, R. J.; Hutson, T. E.; Hudes, G. R.; Figlin, R. A.; Martini, J.; English, P. A.; Wood, L.; Huang, X.; Valota, O.; Williams, J. A.
    Annals of Oncology (2012)

    Fulltext@MSK | Save
  • Axitinib vs sorafenib for advanced renal cell carcinoma: Phase III overall survival results and analysis of prognostic factors
    Meeting Abstract

    Motzer, R. J.; Escudier, B.; Tomczak, P.; Negrier, S.; Gore, M. E.; Tarazi, J.; Hariharan, S.; Rosbrook, B.; Kim, S.; Rini, B. I.
    Annals of Oncology (2012)

    Fulltext@MSK | Save
  • Phase I trial of ASG-5ME in metastatic castration resistant prostate cancer (CRPC)
    Meeting Abstract

    Morris, M.; Bruce, J.; Reyno, L.; Anand, B.; Hartford, A.; Jelaca-Maxwell, K.; Lackey, J.; Eisenberger, M.
    Annals of Oncology (2012)

    Fulltext@MSK | Save
  • A phase IB clinical trial of the multitargeted kinase inhibitor lenvatinib (E7080) in combination with everolimus for treatment of metastatic renal cell carcinoma (RCC)
    Meeting Abstract

    Molina, A. M.; Hutson, T. E.; Larkin, J.; Gold, A.; Andresen, C.; Wood, K.; Motzer, R. J.; Michaelson, M. D.
    Annals of Oncology (2012)

    Fulltext@MSK | Save
  • Phase II study of the combination of bevacizumab plus irinotecan and temozolomide for relapsed or refractory neuroblastoma: Preliminary results
    Meeting Abstract

    Modak, S.; Kushner, B. H.; Kramer, K.; Basu, E.; Roberts, S. S.; Cheung, N. K. V.
    Pediatric Blood and Cancer (2012)

    Fulltext@MSK | Save
  • Haploidentical natural killer cells plus monoclonal antibody 3F8 for resistant high-risk neuroblastoma: Preliminary results of an ongoing phase I study
    Meeting Abstract

    Modak, S.; Cheung, N. K. V.; Kushner, B. H.; Kramer, K.; Basu, E.; Roberts, S. S.; Gallagher, M.; Hsu, K.
    Pediatric Blood and Cancer (2012)

    Fulltext@MSK | Save
  • International multi-institutional management and outcome of patients with positive sentinel lymph nodes (SLNs) in more than one nodal basin
    Meeting Abstract

    Melstrom, L. G.; Taylor, E.; Kuk, D.; Frankel, T. L.; Panageas, K.; Haydu, L.; Sabel, M. S.; Thompson, J. F.; Ariyan, C.; Coit, D. G.; more...
    Annals of Surgical Oncology (2012)

    Fulltext@MSK | Save